Description:

E1105 Hypertension Status Form First-Line Chemotherapy and Trastuzumab With or Without Bevacizumab in Treating Patients With Metastatic Breast Cancer That Overexpresses HER-2/NEU Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=3DA5CD22-EF9E-0E6A-E044-0003BA3F9857

Link:

https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=3DA5CD22-EF9E-0E6A-E044-0003BA3F9857

Keywords:
Versions (6) ▾
  1. 8/26/12
  2. 8/8/14
  3. 8/8/14
  4. 12/16/14
  5. 1/8/15
  6. 8/7/15
Uploaded on:

August 7, 2015

DOI:
No DOI assigned. To request one please log in.
License:
Creative Commons BY-NC 3.0 Legacy
Model comments:

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for:

Item comments for:

In order to download data models you must be logged in. Please log in or register for free.

Hypertension Status Form Breast Cancer E1105 NCT00520975

INSTRUCTIONS: After patient is off treatment, complete this form for each required follow-up report period (see forms submission schedule).

General information
Off Treatment Report Period (since registration)
Reporting Period
On Treatment Report Period (Maintenance 1 cycle = 3 weeks)
mmHg
mmHg
Anti-Hypertensive Drugs
Comments

Similar models